0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nitinol Revascularization Device Market Research Report 2026
Published Date: 2026-02-09
|
Report Code: QYRE-Auto-30E18088
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Nitinol Revascularization Device Market Research Report 2024
BUY CHAPTERS

Global Nitinol Revascularization Device Market Research Report 2026

Code: QYRE-Auto-30E18088
Report
2026-02-09
Pages:134
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nitinol Revascularization Device Market

The global Nitinol Revascularization Device market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Nitinol Revascularization Device competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Nitinol revascularization device is a medical device made from nitinol alloy, designed to restore blood flow in vessels affected by blockages or narrowing. Due to the superelastic properties and shape memory of nitinol, the device can easily adapt to the contours of the blood vessel and provide long-term support. It is commonly used in procedures like angioplasty to treat conditions such as peripheral artery disease (PAD) and other vascular obstructions.
The North American market for Nitinol Revascularization Device is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Nitinol Revascularization Device is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Nitinol Revascularization Device include Rapid Medical, Acandis GmbH, Medtronic, Stryker, Johnson & Johnson MedTech, Suzhou Zhongtian Medical, Micro-Port Shentong Medical, Guichuangtongqiao Medical, Xinkainuo Medical, Jianshi Medical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Nitinol Revascularization Device market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Nitinol Revascularization Device. The Nitinol Revascularization Device market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Nitinol Revascularization Device market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Nitinol Revascularization Device manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Nitinol Revascularization Device Market Report

Report Metric Details
Report Name Nitinol Revascularization Device Market
Segment by Type
  • Diameter 3MM
  • Diameter 4MM
  • Diameter 6MM
  • Other
by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Rapid Medical, Acandis GmbH, Medtronic, Stryker, Johnson & Johnson MedTech, Suzhou Zhongtian Medical, Micro-Port Shentong Medical, Guichuangtongqiao Medical, Xinkainuo Medical, Jianshi Medical, Xinwei Medical, Hemu Biotech, Sinoshenchang Medical, Furukawa Techno Material, Penumbra, Balt Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Nitinol Revascularization Device manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Nitinol Revascularization Device sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Nitinol Revascularization Device Market report?

Ans: The main players in the Nitinol Revascularization Device Market are Rapid Medical, Acandis GmbH, Medtronic, Stryker, Johnson & Johnson MedTech, Suzhou Zhongtian Medical, Micro-Port Shentong Medical, Guichuangtongqiao Medical, Xinkainuo Medical, Jianshi Medical, Xinwei Medical, Hemu Biotech, Sinoshenchang Medical, Furukawa Techno Material, Penumbra, Balt Group

What are the Application segmentation covered in the Nitinol Revascularization Device Market report?

Ans: The Applications covered in the Nitinol Revascularization Device Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Nitinol Revascularization Device Market report?

Ans: The Types covered in the Nitinol Revascularization Device Market report are Diameter 3MM, Diameter 4MM, Diameter 6MM, Other

1 Nitinol Revascularization Device Market Overview
1.1 Product Definition
1.2 Nitinol Revascularization Device by Type
1.2.1 Global Nitinol Revascularization Device Market Value by Type: 2025 vs 2032
1.2.2 Diameter 3MM
1.2.3 Diameter 4MM
1.2.4 Diameter 6MM
1.2.5 Other
1.3 Nitinol Revascularization Device by Application
1.3.1 Global Nitinol Revascularization Device Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Nitinol Revascularization Device Market Size Estimates and Forecasts
1.4.1 Global Nitinol Revascularization Device Revenue 2021–2032
1.4.2 Global Nitinol Revascularization Device Sales 2021–2032
1.4.3 Global Nitinol Revascularization Device Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Nitinol Revascularization Device Market Competition by Manufacturers
2.1 Global Nitinol Revascularization Device Sales Market Share by Manufacturers (2021–2026)
2.2 Global Nitinol Revascularization Device Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Nitinol Revascularization Device Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Nitinol Revascularization Device, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Nitinol Revascularization Device, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Nitinol Revascularization Device, Product Types and Applications
2.7 Global Key Manufacturers of Nitinol Revascularization Device, Date of Entry into the Industry
2.8 Global Nitinol Revascularization Device Market Competitive Situation and Trends
2.8.1 Global Nitinol Revascularization Device Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Nitinol Revascularization Device Players Market Share by Revenue
2.8.3 Global Nitinol Revascularization Device Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nitinol Revascularization Device Market Scenario by Region
3.1 Global Nitinol Revascularization Device Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Nitinol Revascularization Device Sales by Region: 2021–2032
3.2.1 Global Nitinol Revascularization Device Sales by Region: 2021–2026
3.2.2 Global Nitinol Revascularization Device Sales by Region: 2027–2032
3.3 Global Nitinol Revascularization Device Revenue by Region: 2021–2032
3.3.1 Global Nitinol Revascularization Device Revenue by Region: 2021–2026
3.3.2 Global Nitinol Revascularization Device Revenue by Region: 2027–2032
3.4 North America Nitinol Revascularization Device Market Facts & Figures by Country
3.4.1 North America Nitinol Revascularization Device Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Nitinol Revascularization Device Sales by Country (2021–2032)
3.4.3 North America Nitinol Revascularization Device Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nitinol Revascularization Device Market Facts & Figures by Country
3.5.1 Europe Nitinol Revascularization Device Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Nitinol Revascularization Device Sales by Country (2021–2032)
3.5.3 Europe Nitinol Revascularization Device Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nitinol Revascularization Device Market Facts & Figures by Region
3.6.1 Asia Pacific Nitinol Revascularization Device Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Nitinol Revascularization Device Sales by Region (2021–2032)
3.6.3 Asia Pacific Nitinol Revascularization Device Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nitinol Revascularization Device Market Facts & Figures by Country
3.7.1 Latin America Nitinol Revascularization Device Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Nitinol Revascularization Device Sales by Country (2021–2032)
3.7.3 Latin America Nitinol Revascularization Device Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Nitinol Revascularization Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Nitinol Revascularization Device Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Nitinol Revascularization Device Sales by Country (2021–2032)
3.8.3 Middle East and Africa Nitinol Revascularization Device Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nitinol Revascularization Device Sales by Type (2021–2032)
4.1.1 Global Nitinol Revascularization Device Sales by Type (2021–2026)
4.1.2 Global Nitinol Revascularization Device Sales by Type (2027–2032)
4.1.3 Global Nitinol Revascularization Device Sales Market Share by Type (2021–2032)
4.2 Global Nitinol Revascularization Device Revenue by Type (2021–2032)
4.2.1 Global Nitinol Revascularization Device Revenue by Type (2021–2026)
4.2.2 Global Nitinol Revascularization Device Revenue by Type (2027–2032)
4.2.3 Global Nitinol Revascularization Device Revenue Market Share by Type (2021–2032)
4.3 Global Nitinol Revascularization Device Price by Type (2021–2032)
5 Segment by Application
5.1 Global Nitinol Revascularization Device Sales by Application (2021–2032)
5.1.1 Global Nitinol Revascularization Device Sales by Application (2021–2026)
5.1.2 Global Nitinol Revascularization Device Sales by Application (2027–2032)
5.1.3 Global Nitinol Revascularization Device Sales Market Share by Application (2021–2032)
5.2 Global Nitinol Revascularization Device Revenue by Application (2021–2032)
5.2.1 Global Nitinol Revascularization Device Revenue by Application (2021–2026)
5.2.2 Global Nitinol Revascularization Device Revenue by Application (2027–2032)
5.2.3 Global Nitinol Revascularization Device Revenue Market Share by Application (2021–2032)
5.3 Global Nitinol Revascularization Device Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Rapid Medical
6.1.1 Rapid Medical Company Information
6.1.2 Rapid Medical Description and Business Overview
6.1.3 Rapid Medical Nitinol Revascularization Device Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Rapid Medical Nitinol Revascularization Device Product Portfolio
6.1.5 Rapid Medical Recent Developments/Updates
6.2 Acandis GmbH
6.2.1 Acandis GmbH Company Information
6.2.2 Acandis GmbH Description and Business Overview
6.2.3 Acandis GmbH Nitinol Revascularization Device Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Acandis GmbH Nitinol Revascularization Device Product Portfolio
6.2.5 Acandis GmbH Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Nitinol Revascularization Device Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Medtronic Nitinol Revascularization Device Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Stryker
6.4.1 Stryker Company Information
6.4.2 Stryker Description and Business Overview
6.4.3 Stryker Nitinol Revascularization Device Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Stryker Nitinol Revascularization Device Product Portfolio
6.4.5 Stryker Recent Developments/Updates
6.5 Johnson & Johnson MedTech
6.5.1 Johnson & Johnson MedTech Company Information
6.5.2 Johnson & Johnson MedTech Description and Business Overview
6.5.3 Johnson & Johnson MedTech Nitinol Revascularization Device Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Johnson & Johnson MedTech Nitinol Revascularization Device Product Portfolio
6.5.5 Johnson & Johnson MedTech Recent Developments/Updates
6.6 Suzhou Zhongtian Medical
6.6.1 Suzhou Zhongtian Medical Company Information
6.6.2 Suzhou Zhongtian Medical Description and Business Overview
6.6.3 Suzhou Zhongtian Medical Nitinol Revascularization Device Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Suzhou Zhongtian Medical Nitinol Revascularization Device Product Portfolio
6.6.5 Suzhou Zhongtian Medical Recent Developments/Updates
6.7 Micro-Port Shentong Medical
6.7.1 Micro-Port Shentong Medical Company Information
6.7.2 Micro-Port Shentong Medical Description and Business Overview
6.7.3 Micro-Port Shentong Medical Nitinol Revascularization Device Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Micro-Port Shentong Medical Nitinol Revascularization Device Product Portfolio
6.7.5 Micro-Port Shentong Medical Recent Developments/Updates
6.8 Guichuangtongqiao Medical
6.8.1 Guichuangtongqiao Medical Company Information
6.8.2 Guichuangtongqiao Medical Description and Business Overview
6.8.3 Guichuangtongqiao Medical Nitinol Revascularization Device Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Guichuangtongqiao Medical Nitinol Revascularization Device Product Portfolio
6.8.5 Guichuangtongqiao Medical Recent Developments/Updates
6.9 Xinkainuo Medical
6.9.1 Xinkainuo Medical Company Information
6.9.2 Xinkainuo Medical Description and Business Overview
6.9.3 Xinkainuo Medical Nitinol Revascularization Device Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Xinkainuo Medical Nitinol Revascularization Device Product Portfolio
6.9.5 Xinkainuo Medical Recent Developments/Updates
6.10 Jianshi Medical
6.10.1 Jianshi Medical Company Information
6.10.2 Jianshi Medical Description and Business Overview
6.10.3 Jianshi Medical Nitinol Revascularization Device Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Jianshi Medical Nitinol Revascularization Device Product Portfolio
6.10.5 Jianshi Medical Recent Developments/Updates
6.11 Xinwei Medical
6.11.1 Xinwei Medical Company Information
6.11.2 Xinwei Medical Description and Business Overview
6.11.3 Xinwei Medical Nitinol Revascularization Device Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Xinwei Medical Nitinol Revascularization Device Product Portfolio
6.11.5 Xinwei Medical Recent Developments/Updates
6.12 Hemu Biotech
6.12.1 Hemu Biotech Company Information
6.12.2 Hemu Biotech Description and Business Overview
6.12.3 Hemu Biotech Nitinol Revascularization Device Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Hemu Biotech Nitinol Revascularization Device Product Portfolio
6.12.5 Hemu Biotech Recent Developments/Updates
6.13 Sinoshenchang Medical
6.13.1 Sinoshenchang Medical Company Information
6.13.2 Sinoshenchang Medical Description and Business Overview
6.13.3 Sinoshenchang Medical Nitinol Revascularization Device Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Sinoshenchang Medical Nitinol Revascularization Device Product Portfolio
6.13.5 Sinoshenchang Medical Recent Developments/Updates
6.14 Furukawa Techno Material
6.14.1 Furukawa Techno Material Company Information
6.14.2 Furukawa Techno Material Description and Business Overview
6.14.3 Furukawa Techno Material Nitinol Revascularization Device Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Furukawa Techno Material Nitinol Revascularization Device Product Portfolio
6.14.5 Furukawa Techno Material Recent Developments/Updates
6.15 Penumbra
6.15.1 Penumbra Company Information
6.15.2 Penumbra Description and Business Overview
6.15.3 Penumbra Nitinol Revascularization Device Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Penumbra Nitinol Revascularization Device Product Portfolio
6.15.5 Penumbra Recent Developments/Updates
6.16 Balt Group
6.16.1 Balt Group Company Information
6.16.2 Balt Group Description and Business Overview
6.16.3 Balt Group Nitinol Revascularization Device Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Balt Group Nitinol Revascularization Device Product Portfolio
6.16.5 Balt Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nitinol Revascularization Device Industry Chain Analysis
7.2 Nitinol Revascularization Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nitinol Revascularization Device Production Mode & Process Analysis
7.4 Nitinol Revascularization Device Sales and Marketing
7.4.1 Nitinol Revascularization Device Sales Channels
7.4.2 Nitinol Revascularization Device Distributors
7.5 Nitinol Revascularization Device Customer Analysis
8 Nitinol Revascularization Device Market Dynamics
8.1 Nitinol Revascularization Device Industry Trends
8.2 Nitinol Revascularization Device Market Drivers
8.3 Nitinol Revascularization Device Market Challenges
8.4 Nitinol Revascularization Device Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Nitinol Revascularization Device Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Nitinol Revascularization Device Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Nitinol Revascularization Device Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Nitinol Revascularization Device Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Nitinol Revascularization Device Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Nitinol Revascularization Device Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Nitinol Revascularization Device Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Nitinol Revascularization Device Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Nitinol Revascularization Device, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Nitinol Revascularization Device, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Nitinol Revascularization Device, Product Types and Applications
 Table 12. Global Key Manufacturers of Nitinol Revascularization Device, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Nitinol Revascularization Device Companies by Tier (Tier 1, Tier 2, Tier 3), based on Nitinol Revascularization Device Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Nitinol Revascularization Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Nitinol Revascularization Device Sales by Region (K Units), 2021–2026
 Table 18. Global Nitinol Revascularization Device Sales Market Share by Region (2021–2026)
 Table 19. Global Nitinol Revascularization Device Sales by Region (K Units), 2027–2032
 Table 20. Global Nitinol Revascularization Device Sales Market Share by Region (2027–2032)
 Table 21. Global Nitinol Revascularization Device Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Nitinol Revascularization Device Revenue Market Share by Region (2021–2026)
 Table 23. Global Nitinol Revascularization Device Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Nitinol Revascularization Device Revenue Market Share by Region (2027–2032)
 Table 25. North America Nitinol Revascularization Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Nitinol Revascularization Device Sales by Country (K Units), 2021–2026
 Table 27. North America Nitinol Revascularization Device Sales by Country (K Units), 2027–2032
 Table 28. North America Nitinol Revascularization Device Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Nitinol Revascularization Device Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Nitinol Revascularization Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Nitinol Revascularization Device Sales by Country (K Units), 2021–2026
 Table 32. Europe Nitinol Revascularization Device Sales by Country (K Units), 2027–2032
 Table 33. Europe Nitinol Revascularization Device Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Nitinol Revascularization Device Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Nitinol Revascularization Device Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Nitinol Revascularization Device Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Nitinol Revascularization Device Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Nitinol Revascularization Device Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Nitinol Revascularization Device Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Nitinol Revascularization Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Nitinol Revascularization Device Sales by Country (K Units), 2021–2026
 Table 42. Latin America Nitinol Revascularization Device Sales by Country (K Units), 2027–2032
 Table 43. Latin America Nitinol Revascularization Device Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Nitinol Revascularization Device Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Nitinol Revascularization Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Nitinol Revascularization Device Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Nitinol Revascularization Device Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Nitinol Revascularization Device Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Nitinol Revascularization Device Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Nitinol Revascularization Device Sales (K Units) by Type (2021–2026)
 Table 51. Global Nitinol Revascularization Device Sales (K Units) by Type (2027–2032)
 Table 52. Global Nitinol Revascularization Device Sales Market Share by Type (2021–2026)
 Table 53. Global Nitinol Revascularization Device Sales Market Share by Type (2027–2032)
 Table 54. Global Nitinol Revascularization Device Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Nitinol Revascularization Device Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Nitinol Revascularization Device Revenue Market Share by Type (2021–2026)
 Table 57. Global Nitinol Revascularization Device Revenue Market Share by Type (2027–2032)
 Table 58. Global Nitinol Revascularization Device Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Nitinol Revascularization Device Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Nitinol Revascularization Device Sales (K Units) by Application (2021–2026)
 Table 61. Global Nitinol Revascularization Device Sales (K Units) by Application (2027–2032)
 Table 62. Global Nitinol Revascularization Device Sales Market Share by Application (2021–2026)
 Table 63. Global Nitinol Revascularization Device Sales Market Share by Application (2027–2032)
 Table 64. Global Nitinol Revascularization Device Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Nitinol Revascularization Device Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Nitinol Revascularization Device Revenue Market Share by Application (2021–2026)
 Table 67. Global Nitinol Revascularization Device Revenue Market Share by Application (2027–2032)
 Table 68. Global Nitinol Revascularization Device Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Nitinol Revascularization Device Price (US$/Unit) by Application (2027–2032)
 Table 70. Rapid Medical Company Information
 Table 71. Rapid Medical Description and Business Overview
 Table 72. Rapid Medical Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Rapid Medical Nitinol Revascularization Device Product
 Table 74. Rapid Medical Recent Developments/Updates
 Table 75. Acandis GmbH Company Information
 Table 76. Acandis GmbH Description and Business Overview
 Table 77. Acandis GmbH Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Acandis GmbH Nitinol Revascularization Device Product
 Table 79. Acandis GmbH Recent Developments/Updates
 Table 80. Medtronic Company Information
 Table 81. Medtronic Description and Business Overview
 Table 82. Medtronic Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Medtronic Nitinol Revascularization Device Product
 Table 84. Medtronic Recent Developments/Updates
 Table 85. Stryker Company Information
 Table 86. Stryker Description and Business Overview
 Table 87. Stryker Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Stryker Nitinol Revascularization Device Product
 Table 89. Stryker Recent Developments/Updates
 Table 90. Johnson & Johnson MedTech Company Information
 Table 91. Johnson & Johnson MedTech Description and Business Overview
 Table 92. Johnson & Johnson MedTech Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Johnson & Johnson MedTech Nitinol Revascularization Device Product
 Table 94. Johnson & Johnson MedTech Recent Developments/Updates
 Table 95. Suzhou Zhongtian Medical Company Information
 Table 96. Suzhou Zhongtian Medical Description and Business Overview
 Table 97. Suzhou Zhongtian Medical Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Suzhou Zhongtian Medical Nitinol Revascularization Device Product
 Table 99. Suzhou Zhongtian Medical Recent Developments/Updates
 Table 100. Micro-Port Shentong Medical Company Information
 Table 101. Micro-Port Shentong Medical Description and Business Overview
 Table 102. Micro-Port Shentong Medical Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Micro-Port Shentong Medical Nitinol Revascularization Device Product
 Table 104. Micro-Port Shentong Medical Recent Developments/Updates
 Table 105. Guichuangtongqiao Medical Company Information
 Table 106. Guichuangtongqiao Medical Description and Business Overview
 Table 107. Guichuangtongqiao Medical Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Guichuangtongqiao Medical Nitinol Revascularization Device Product
 Table 109. Guichuangtongqiao Medical Recent Developments/Updates
 Table 110. Xinkainuo Medical Company Information
 Table 111. Xinkainuo Medical Description and Business Overview
 Table 112. Xinkainuo Medical Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Xinkainuo Medical Nitinol Revascularization Device Product
 Table 114. Xinkainuo Medical Recent Developments/Updates
 Table 115. Jianshi Medical Company Information
 Table 116. Jianshi Medical Description and Business Overview
 Table 117. Jianshi Medical Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Jianshi Medical Nitinol Revascularization Device Product
 Table 119. Jianshi Medical Recent Developments/Updates
 Table 120. Xinwei Medical Company Information
 Table 121. Xinwei Medical Description and Business Overview
 Table 122. Xinwei Medical Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Xinwei Medical Nitinol Revascularization Device Product
 Table 124. Xinwei Medical Recent Developments/Updates
 Table 125. Hemu Biotech Company Information
 Table 126. Hemu Biotech Description and Business Overview
 Table 127. Hemu Biotech Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Hemu Biotech Nitinol Revascularization Device Product
 Table 129. Hemu Biotech Recent Developments/Updates
 Table 130. Sinoshenchang Medical Company Information
 Table 131. Sinoshenchang Medical Description and Business Overview
 Table 132. Sinoshenchang Medical Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Sinoshenchang Medical Nitinol Revascularization Device Product
 Table 134. Sinoshenchang Medical Recent Developments/Updates
 Table 135. Furukawa Techno Material Company Information
 Table 136. Furukawa Techno Material Description and Business Overview
 Table 137. Furukawa Techno Material Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Furukawa Techno Material Nitinol Revascularization Device Product
 Table 139. Furukawa Techno Material Recent Developments/Updates
 Table 140. Penumbra Company Information
 Table 141. Penumbra Description and Business Overview
 Table 142. Penumbra Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Penumbra Nitinol Revascularization Device Product
 Table 144. Penumbra Recent Developments/Updates
 Table 145. Balt Group Company Information
 Table 146. Balt Group Description and Business Overview
 Table 147. Balt Group Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Balt Group Nitinol Revascularization Device Product
 Table 149. Balt Group Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Nitinol Revascularization Device Distributors List
 Table 153. Nitinol Revascularization Device Customers List
 Table 154. Nitinol Revascularization Device Market Trends
 Table 155. Nitinol Revascularization Device Market Drivers
 Table 156. Nitinol Revascularization Device Market Challenges
 Table 157. Nitinol Revascularization Device Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Nitinol Revascularization Device
 Figure 2. Global Nitinol Revascularization Device Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Nitinol Revascularization Device Market Share by Type: 2025 & 2032
 Figure 4. Diameter 3MM Product Picture
 Figure 5. Diameter 4MM Product Picture
 Figure 6. Diameter 6MM Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Nitinol Revascularization Device Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Nitinol Revascularization Device Market Share by Application: 2025 & 2032
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Other
 Figure 13. Global Nitinol Revascularization Device Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Nitinol Revascularization Device Market Size (US$ Million), 2021–2032
 Figure 15. Global Nitinol Revascularization Device Sales (K Units), 2021–2032
 Figure 16. Global Nitinol Revascularization Device Average Price (US$/Unit), 2021–2032
 Figure 17. Nitinol Revascularization Device Report Years Considered
 Figure 18. Nitinol Revascularization Device Sales Share by Manufacturers in 2025
 Figure 19. Global Nitinol Revascularization Device Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global Nitinol Revascularization Device Players: Market Share by Revenue in Nitinol Revascularization Device in 2025
 Figure 21. Nitinol Revascularization Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global Nitinol Revascularization Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America Nitinol Revascularization Device Sales Market Share by Country (2021–2032)
 Figure 24. North America Nitinol Revascularization Device Revenue Market Share by Country (2021–2032)
 Figure 25. United States Nitinol Revascularization Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada Nitinol Revascularization Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe Nitinol Revascularization Device Sales Market Share by Country (2021–2032)
 Figure 28. Europe Nitinol Revascularization Device Revenue Market Share by Country (2021–2032)
 Figure 29. Germany Nitinol Revascularization Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France Nitinol Revascularization Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. Nitinol Revascularization Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy Nitinol Revascularization Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia Nitinol Revascularization Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific Nitinol Revascularization Device Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific Nitinol Revascularization Device Revenue Market Share by Region (2021–2032)
 Figure 36. China Nitinol Revascularization Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan Nitinol Revascularization Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea Nitinol Revascularization Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India Nitinol Revascularization Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia Nitinol Revascularization Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. China Taiwan Nitinol Revascularization Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Southeast Asia Nitinol Revascularization Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Nitinol Revascularization Device Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Nitinol Revascularization Device Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Nitinol Revascularization Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Nitinol Revascularization Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Nitinol Revascularization Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Colombia Nitinol Revascularization Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Nitinol Revascularization Device Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Nitinol Revascularization Device Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Nitinol Revascularization Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Nitinol Revascularization Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Nitinol Revascularization Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Nitinol Revascularization Device by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Nitinol Revascularization Device by Type (2021–2032)
 Figure 56. Global Nitinol Revascularization Device Price (US$/Unit) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Nitinol Revascularization Device by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Nitinol Revascularization Device by Application (2021–2032)
 Figure 59. Global Nitinol Revascularization Device Price (US$/Unit) by Application (2021–2032)
 Figure 60. Nitinol Revascularization Device Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS